Literature DB >> 32354935

Expression and Prognostic Significance of CDK8 and β-Catenin in Hepatocellular Carcinoma.

Song Iy Han1, Sung-Chul Lim2.   

Abstract

BACKGROUND/AIM: Cyclin-dependent kinase 8 (CDK8) is known to play an important role in the early development and progression of various cancers, and the Wnt/β-catenin pathway is also involved in cancer progression. Nevertheless, relatively little is known about the regulatory mechanisms of the β-catenin pathway in hepatocellular carcinoma (HCC).
MATERIALS AND METHODS: The complete clinicopathological features of 122 pairs of HCC and adjacent non-tumor tissues were analyzed and immunohistochemistry was used to detect the aberrant expression of CDK8 and β-catenin. Overall survival rates (OSRs) were evaluated using the Kaplan-Meier method and Cox multivariate analysis was used to assess the prognostic values.
RESULTS: Aberrant expression of nuclear β-catenin and CDK8 are independent prognostic variables that negatively affect the OSR. The aberrant expression of CDK8 was associated with the dysregulated expression of β-catenin and correlated with a poor prognosis.
CONCLUSION: Inhibition of CDK8 and/or nuclear β-catenin expression pattern could serve as a promising therapeutic strategy for the treatment of HCC. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  CDK8; Liver; biomarkers; hepatocellular carcinoma; β-catenin

Mesh:

Substances:

Year:  2020        PMID: 32354935      PMCID: PMC7279855          DOI: 10.21873/invivo.11918

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  31 in total

1.  A molecular mechanism that links Hippo signalling to the inhibition of Wnt/β-catenin signalling.

Authors:  Masamichi Imajo; Koichi Miyatake; Akira Iimura; Atsumu Miyamoto; Eisuke Nishida
Journal:  EMBO J       Date:  2012-01-10       Impact factor: 11.598

2.  beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance.

Authors:  C M Wong; S T Fan; I O Ng
Journal:  Cancer       Date:  2001-07-01       Impact factor: 6.860

3.  Mediator is a transducer of Wnt/beta-catenin signaling.

Authors:  Seokjoong Kim; Xuan Xu; Andreas Hecht; Thomas G Boyer
Journal:  J Biol Chem       Date:  2006-03-24       Impact factor: 5.157

4.  E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8.

Authors:  Erick J Morris; Jun-Yuan Ji; Fajun Yang; Luisa Di Stefano; Anabel Herr; Nam-Sung Moon; Eun-Jeong Kwon; Kevin M Haigis; Anders M Näär; Nicholas J Dyson
Journal:  Nature       Date:  2008-09-14       Impact factor: 49.962

5.  Blending hippo and WNT: sharing messengers and regulation.

Authors:  Becky P Tsai; Nate P Hoverter; Marian L Waterman
Journal:  Cell       Date:  2012-12-21       Impact factor: 41.582

6.  NK Cell-Specific CDK8 Deletion Enhances Antitumor Responses.

Authors:  Agnieszka Witalisz-Siepracka; Dagmar Gotthardt; Michaela Prchal-Murphy; Zrinka Didara; Ingeborg Menzl; Daniela Prinz; Leo Edlinger; Eva Maria Putz; Veronika Sexl
Journal:  Cancer Immunol Res       Date:  2018-01-31       Impact factor: 11.151

7.  Purification of a 92-kDa cytoplasmic protein tightly associated with the cell-cell adhesion molecule E-cadherin (uvomorulin). Characterization and extractability of the protein complex from the cell cytostructure.

Authors:  P D McCrea; B M Gumbiner
Journal:  J Biol Chem       Date:  1991-03-05       Impact factor: 5.157

8.  Identification of the β-catenin/JNK/prothymosin-alpha axis as a novel target of sorafenib in hepatocellular carcinoma cells.

Authors:  Yi-Te Lin; Chuck C-K Chao
Journal:  Oncotarget       Date:  2015-11-17

9.  Inhibition of CDK8 mediator kinase suppresses estrogen dependent transcription and the growth of estrogen receptor positive breast cancer.

Authors:  Martina S J McDermott; Alexander A Chumanevich; Chang-Uk Lim; Jiaxin Liang; Mengqian Chen; Serena Altilia; David Oliver; James M Rae; Michael Shtutman; Hippokratis Kiaris; Balázs Győrffy; Igor B Roninson; Eugenia V Broude
Journal:  Oncotarget       Date:  2017-02-21

10.  Promotion of growth factor signaling as a critical function of β-catenin during HCC progression.

Authors:  Eunsun Kim; Amanda Lisby; Connie Ma; Nathanael Lo; Ursula Ehmer; Katharina E Hayer; Emma E Furth; Patrick Viatour
Journal:  Nat Commun       Date:  2019-04-23       Impact factor: 14.919

View more
  1 in total

Review 1.  CDK10 in Gastrointestinal Cancers: Dual Roles as a Tumor Suppressor and Oncogene.

Authors:  Zainab A Bazzi; Isabella T Tai
Journal:  Front Oncol       Date:  2021-06-30       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.